A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

NCT06680531 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Central Nervous System

Interventions

DRUG: YZJ-1139 tablets
DRUG: Escitalopram oxalate tablets
DRUG: YZJ-1139 simulated tablets

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.